04 january 2023
News
30 november 2022
News
Harnessing the similarities of US and European Clinical Trial Applications
13 october 2022
News
The five key steps of the Quality by Design systematic approach for drug development
07 october 2022
News
EMA Gives Extra Time to Marketing Authorization Holders to Manage Nitrosamine Risk
19 july 2022
News
Brazil – Shorter Timelines for CTA (Clinical Trial Applications) Assessment
11 july 2022
News
Navigating the EAEU legislative changes for Medicinal Products
05 july 2022
News
PLG as Interim Marketing Authorisation Holder
10 june 2022
News
South Africa Adopts EU Marketing Authorization Guidelines to Ensure Timely Approval
27 may 2022
News